As I understand and until today I see pretty much all

New Post Public Reply Private Reply Replies (0) Message Board
aidenb havasu78 #41093
753
As I understand and until today I see pretty much all companies do the same. They take a wild guess on the indications and do a an animal study. The take a wild guess on what the primary end point it percentage wise and try to hit it. That's the way FDA approves as well.


After Patternson I now understand primary endpoint is the most meaningless standard out there. Its just there to follow the crowd. He analyses and understands why and how something is working.. He has so many parents and products on measuring results..

He made me think until today no drug company really understood what they were doing it was and is always some statistics based on overall health of the patients, not details in their blood stream..

So, we are all good... Blinded based on FDA standards.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 0

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 1

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 0

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Larry Ellison's Moves Signal Confidence in Oracle's Future

Updated Category News Views 2

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 2

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 0

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading

Top 5 Most Recently Viewed Articles

Politan Capital Advocates for Independent Board Changes at Masimo

Updated Category News Views 103

Politan Capital Pushes for Change in Masimo's Boardroom Politan Capital Management, a major stakeholder in Masimo Corporation (NASDAQ: MASI) with a shareholding of 8.9%, is calling on fellow shareholders to back its efforts to reform the board of Masimo. As the Annual Meeting approaches, the company seeks to introduce new perspectives by electing independent directors who...

Continue Reading
Paratus Energy Services Plans Tender Offer for Senior Notes

Updated Category News Views 217

Overview of the Tender Offer by Paratus Energy Services Ltd. Paratus Energy Services Ltd. has announced a significant cash tender offer aimed at purchasing up to $17,607,991 in Senior Secured Notes, which are due in 2026. This strategic move follows the company's previous successful share sales, showcasing its commitment to enhancing its financial position and shareholder...

Continue Reading
Sigma Foods Achieves Significant EBITDA Growth in 2025

Updated Category News Views 134

Sigma Foods Reports Impressive EBITDA Figures for 2025 Sigma Foods has announced remarkable financial results for the fourth quarter and full year of 2025, showcasing a robust EBITDA of US $278 million in 4Q25, contributing to a total of US $1.1 billion in the entire year. These impressive metrics reflect the company's successful strategies and dedication to driving...

Continue Reading
Verkkokauppa.com Streamlines Operations for Profitable Growth

Updated Category News Views 59

Verkkokauppa.com Completes Organizational Restructuring Verkkokauppa.com Oyj has recently completed significant change negotiations aimed at renewing and streamlining its organizational structure. This initiative is designed to foster profitable growth and enhance operational efficiency across various departments. Goals for Organizational Change The restructuring plan,...

Continue Reading
CTV's W5 Spotlight on Quantum BioPharma and Stock Manipulation

Updated Category News Views 260

Highlights from W5's Investigation into Quantum BioPharma Quantum BioPharma Ltd. (NASDAQ: QNTM) is currently at the center of a significant investigation featured in the acclaimed Canadian television program, W5. The program's second segment delves into the serious allegations of stock market manipulation against two major Canadian banks. This revelation has arisen from...

Continue Reading